Skip to main content
Caplight Logo









Neuvana

Neuvana

Private
Boca Raton, FloridaHealthcare & Life Scienceshttps://neuvanalife.com/

Last Round

Crowdfunding

Jun 1, 2016

Total Funding Raised

$1.1M

Company Overview

Neuvana operates in Healthcare & Life Sciences and is based in Boca Raton, Florida. Its latest recorded funding round was a Crowdfunding round in June 2016.

Neuvana is a wellness technology company that develops non-invasive vagus nerve stimulation devices designed to improve sleep, reduce stress, and enhance focus.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Consumer Electronics, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Neuvana Comparables

Compare Neuvana with similar companies based on industry and business-model similarity.

Neuvana comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vagustim
88%
Sensate
88%
AMO Lab
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Neuvana Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJun 1, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ami Brannon

Chief Executive Officer, CoFounder, Board Member

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 55% MoM.

  • Jan 5, 2026

    Monthly visitors increased 30% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Neuvana Filings

Explore SEC and related filing metadata, where available.

Neuvana filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Neuvana's valuation, stock price, and market status.

Is Neuvana a public or private company?

Neuvana is a private company.

What is the current stock price of Neuvana?

Neuvana is a private company, so its shares have no public market price. Caplight tracks Neuvana's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Neuvana worth (valuation)?

Valuation information for Neuvana is not publicly available.

Can I buy Neuvana stock?

Neuvana shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Neuvana's last funding round?

Neuvana's most recent funding round was Crowdfunding on June 1, 2016.

Who are the main investors in Neuvana?

Investor information for Neuvana is not publicly disclosed.

Will Neuvana IPO soon?

No public IPO plans have been announced for Neuvana.

How can I track Neuvana secondary market activity?

Caplight tracks bids, offers, and trades in Neuvana's shares on secondary markets.

Firmographic Details

HeadquartersBoca Raton, Florida
Employee Range5
Year Founded2014
Last FundingJun 1, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?